@James Of course.
This is my futuristic view of pharmaceutical studies, that, biologic macromolecules have "core design principles" that will be discovered. By "design", I try to emphasize that they aren't just evolutionarily conserved random combinations of monomers which gained functions over thousands of years. Or, are they?
So I tried to say, discovering these design principles is enough to calculate screening results. Leaving simulations unnecessary to deal with. But you said that currently simulations are used to roughly eliminate terrible candidates. So I am o.k. with simulations no…